MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk. (18th August 2017)
- Record Type:
- Journal Article
- Title:
- MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk. (18th August 2017)
- Main Title:
- MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk
- Authors:
- Ouni, Nesrine
Ben Chaaben, Arij
Kablouti, Ghalia
Lajnef, Mohamed
Ayari, Fayza
Abaza, Hajer
Damak, Tarek
Harzallah, Latifa
Benammar-Elgaaeid, Amel
Guemira, Fethi
Tamouza, Ryad - Abstract:
- ABSTRACT: The major histocompatibility complex class I-related chain A (MICA), expressed on cell surface, plays an important role in the elimination of both virus-infected cells and tumor through the activation of the natural killer (NK) receptor NKG2D. A polymorphic change from methionine (Met) to valine (Val) at amino acid position 129 categorizes MICA alleles into strong and weak binders for the NKG2D receptor and has been found in a variety of immune-related disorders. In this study, we investigated the potential interaction between genetic polymorphism of MICA and the development of breast cancer. We recruited 192 unrelated Tunisian women affected by breast cancer and 205 controls age-matched women, all genotyped for MICA-129 Met/Val (rs 1051792). A significant association was found between the Val allele and Val/Val genotype and the risk of breast cancer ( p = 0.002, OR = 1.64, 95% CI = [1.17–2.27]; p = 0.002, OR = 1.88, 95% CI = [1.24–2.87], respectively). After stratification with clinical-pathology parameters, we found that 71% of women aged lower than 40 years had a Val/Val genotype versus 49% (p = 0.014) . About 72% of these patients having a family history of cancers had a Val/Val genotype ( p = 0.04 ). These results suggest that tumor escape mechanism because of failure in order to activate NK cells by MICA-129 Val allele may play a role in individual susceptibility for breast cancer development in Tunisian women.
- Is Part Of:
- Immunological investigations. Volume 46:Number 6(2017)
- Journal:
- Immunological investigations
- Issue:
- Volume 46:Number 6(2017)
- Issue Display:
- Volume 46, Issue 6 (2017)
- Year:
- 2017
- Volume:
- 46
- Issue:
- 6
- Issue Sort Value:
- 2017-0046-0006-0000
- Page Start:
- 603
- Page End:
- 614
- Publication Date:
- 2017-08-18
- Subjects:
- Breast cancer -- early onset -- MICA -- polymorphism -- risk
Immunology -- Periodicals
Immunochemistry -- Periodicals
Cellular immunity -- Periodicals
Communicable diseases -- Periodicals
616.079 - Journal URLs:
- http://informahealthcare.com/journal/imm ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/08820139.2017.1336175 ↗
- Languages:
- English
- ISSNs:
- 0882-0139
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.682500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2942.xml